Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome versus ropivacaine quadratus lumborum block in laparoscopic total abdominal hysterectomy
ChiCTR2400080561Phase 4Recruiting
- Sponsor
- Linyi People's Hospital
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Bupivacaine liposome injection group with Ropivacaine hydrochloride group (2 arms). Primary endpoint: Analgesic effect in 0-72 hours after surgery. Started Feb 2024; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080561.